A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Colleagues Introduce Legislation Countering Iran-China Ties
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Marsha Blackburn (R-TN) introduced the Iran China Accountability Act. The bill would prohibit the provision of taxpayer dollars to advance a nuclear agreement with Iran until the Iranian regime terminates its ties with the Chinese Communist Party and terrorist groups like Hamas.
“A renewed nuclear deal with Iran would not only benefit the regime in Tehran, it would similarly reward and enrich the Chinese Communist Party,” Rubio said. “We cannot allow the Biden Administration to continue making concessions to dictators in return for empty promises. It is dangerous and anti-American.”
“The Obama-Biden Iran Deal has always been a failure,” Blackburn said. “The Biden Administration should not re-enter a deal that legitimizes the Iranian regime — especially while they continue to fund terrorism, endorse Communist China’s dangerous government, and facilitate genocide. This legislation will stop taxpayer dollars from enabling the Biden White House to back this corrupt regime.”
Senators Rick Scott (R-FL), Bill Cassidy (R-LA), Thom Tillis (R-NC), Mike Braun (R-IN), and Ted Cruz (R-TX) are original cosponsors. Congressman Bob Good (R-VA) introduced companion legislation in the House of Representatives.
Specifically, the Iran China Accountability Act would:
- Require any nuclear agreement to be ratified by a two-thirds vote of the U.S. Senate;
- Prohibit the obligation or expenditure of any funds for a nuclear agreement until:
- Iran terminates all agreements involving the transfer of funds from China and terminates strategic security and military partnerships with China,
- Iran terminates all ties and transfers of cash to Iranian proxy forces (including Hamas)
- Iran verifies the destruction of all chemical weapons/materials/infrastructure, and
- The CCP ceases the incarceration of Uyghurs;
- Require a report from the Secretary of State to Congress detailing how any future agreement with Iran would meet each requirement listed above; and
- Condemn Hamas-incited terrorist attacks on Israel.
Related: